Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enoxaparin Metabolism in Reconstructive Surgery Patients

NCT02411292 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT02411292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02411292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enoxaparin Metabolism in Reconstructive Surgery Patients
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2016
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep venous thrombosis, pulmonary embolus, reconstructive surgery, venous thromboembolism